Vectura Group – a listed, UK-based developer of inhaled drug delivery devices – has approved a take-private offer from Carlyle valuing the business at £958m.
Laboratory and imaging diagnostics service is valued at more than EUR 5bn
IK expanded its UK operations to include a local small-cap team headed by partner Tom Salmon in 2020
Asset manager nets a 10.7% IRR on the investment in its listed peer
Romanian cybersecurity company appoints JP Morgan and Morgan Stanley for a dual-track process